1. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. New Engl J Med. 1985;312(3):159-163.
2. Farmer DG, Amersi F, Kupiec-Weglinski J, Busuttil RW. Current status of ischemia and reperfusion injury in the liver. Transplant Rev. 2000;14(2):106-126.
3. Collard CD, Gelman S. Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury. Anesthesiology. 2001;94(6):1133-1138.
4. Nace GW, Huang H, Klune JR, et al. Cellular-specific role of tolllike receptor 4 in hepatic ischemia-reperfusion injury in mice. Hepatology (Baltimore, MD). 2013;58(1):374-387.
5. van Golen RF, Reiniers MJ, Marsman G, et al. The damage-associated molecular pattern HMGB1 is released early after clinical hepatic ischemia/reperfusion. Biochim Biophys Acta. 2019;1865(6):1192-1200.
6. Scheuermann U, Zhu M, Song M, et al. Damage-associated molecular patterns induce inflammatory injury during machine preservation of the liver: potential targets to enhance a promising technology. Liver Transplant. 2019;25(4):610-626.
7. Kadono K, Uchida Y, Hirao H, et al. Thrombomodulin attenuates inflammatory damage due to liver ischemia and reperfusion injury in mice in toll-like receptor 4-dependent manner. Am J Transplant. 2017;17(1):69-80.
8. Fuentes-Prior P, Iwanaga Y, Huber R, et al. Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex. Nature. 2000;404(6777):518-525.
9. Ikezoe T. Thrombomodulin/activated protein C system in septic disseminated intravascular coagulation. J Intensive Care. 2015;3(1):1.
10. Stearns-Kurosawa DJ, Kurosawa S, Mollica JS, Ferrell GL, Esmon CT. The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex. Proc Natl Acad Sci USA. 1996;93(19):10212-10216.
11. Mori S, Ai T, Sera T, Ochiai K, Otomo Y. Human Soluble Recombinant Thrombomodulin, ART-123, resolved early phase coagulopathies, but did not significantly alter the 28 day outcome in the treatment of DIC associated with infectious systemic inflammatory response syndromes. J Clin Med. 2019;8(10):1553.
12. Kashiwadate T, Miyagi S, Hara Y, et al. Recombinant human soluble thrombomodulin (ART-123) prevents warm ischemia-reperfusion injury in liver grafts from non-heart-beating donors. Transpl Proc. 2012;44(2):369-372.
13. Kashiwadate T, Miyagi S, Hara Y, et al. Soluble thrombomodulin ameliorates ischemia-reperfusion injury of liver grafts by modulating the proinflammatory role of high-mobility group box 1. Tohoku J Exp Med. 2016;239(4):315-323.
14. Kimura K, Yoshizumi T, Inokuchi S, et al. Potential effect of recombinant thrombomodulin on ischemia-reperfusion liver injury in rats. Hepatol Res. 2018;48(5):391-396.
15. Loghmani H, Conway EM. Exploring traditional and nontraditional roles for thrombomodulin. Blood. 2018;132(2):148-158.
16. Sharfuddin AA, Sandoval RM, Berg DT, et al. Soluble thrombomodulin protects ischemic kidneys. J Am Soc Nephrol: JASN. 2009;20(3):524-534.
17. Tanemura A, Kuriyama N, Azumi Y, et al. Thrombomodulin administration attenuates ischemia-reperfusion injury of the remnant liver after 70% hepatectomy in rats: simulated model of smallfor-size graft in living donor liver transplantation. Transpl Proc. 2014;46(4):1107-1111.
18. Abeyama K, Stern DM, Ito Y, et al. The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism. J Clin Investig. 2005;115(5):1267-1274.
19. Lattenist L, Teske G, Claessen N, Florquin S, Conway EM, Roelofs JJ. The lectin like domain of thrombomodulin is involved in the defence against pyelonephritis. Thromb Res. 2015;136(6):1325-1331.
20. Shi C-S, Shi G-Y, Hsiao H-M, et al. Lectin-like domain of thrombomodulin binds to its specific ligand Lewis Y antigen and neutralizes lipopolysaccharide-induced inflammatory response. Blood. 2008;112(9):3661-3670.
21. Geudens N, Van de Wouwer M, Vanaudenaerde BM, et al. The lectin-like domain of thrombomodulin protects against ischaemia-reperfusion lung injury. Eur Respiratory J. 2008;32(4):862-870.
22. Herzog C, Lorenz A, Gillmann H-J, et al. Thrombomodulin's lectin-like domain reduces myocardial damage by interfering with HMGB1- mediated TLR2 signalling. Cardiovasc Res. 2014;101(3):400-410.
23. Miyauchi T, Uchida Y, Kadono K, et al. Preventive effect of antioxidative nutrient-rich enteral diet against liver ischemia and reperfusion injury. JPEN J Parenter Enteral Nutr. 2019;43(1):133-144.
24. Miyauchi T, Uchida Y, Kadono K, et al. Up-regulation of FOXO1 and reduced inflammation by beta-hydroxybutyric acid are essential diet restriction benefits against liver injury. Proc Natl Acad Sci USA. 2019;116(27):13533-13542.
25. Suzuki S, Toledo-Pereyra LH, Rodriguez FJ, Cejalvo D. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine. Transplantation. 1993;55:1265-1272.
26. Rudiger HA, Clavien PA. Tumor necrosis factor alpha, but not Fas, mediates hepatocellular apoptosis in the murine ischemic liver. Gastroenterology. 2002;122(1):202-210.
27. Kohli V, Madden JF, Bentley RC, Clavien PA. Calpain mediates ischemic injury of the liver through modulation of apoptosis and necrosis. Gastroenterology. 1999;116(1):168-178.
28. Kohli V, Selzner M, Madden JF, Bentley RC, Clavien PA. Endothelial cell and hepatocyte deaths occur by apoptosis after ischemia-reperfusion injury in the rat liver. Transplantation. 1999;67(8):1099-1105.
29. Colletti LM, Kunkel SL, Walz A, et al. The role of cytokine networks in the local liver injury following hepatic ischemia/reperfusion in the rat. Hepatology (Baltimore, MD). 1996;23(3):506-514.
30. Palomino DC, Marti LC. Chemokines and immunity. Einstein (Sao Paulo, Brazil). 2015;13(3):469-473.
31. Lentsch AB, Yoshidome H, Cheadle WG, Miller FN, Edwards MJ. Chemokine involvement in hepatic ischemia/reperfusion injury in mice: roles for macrophage inflammatory protein-2 and KC. Hepatology (Baltimore, MD). 1998;27(4):1172-1177.
32. Tsung A, Sahai R, Tanaka H, et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med. 2005;201(7):1135-1143.
33. Conway EM. Thrombomodulin and its role in inflammation. Semin Immunopathol. 2012;34(1):107-125.
34. Aoki N, Matsuda T, Saito H, et al. A comparative double-blind randomized trial of activated protein C and unfractionated heparin in the treatment of disseminated intravascular coagulation. Int J Hematol. 2002;75(5):540-547.
35. Li YH, Kuo CH, Shi GY, Wu HL. The role of thrombomodulin lectin-like domain in inflammation. J Biomed Sci. 2012;19:34.
36. Quesnelle KM, Bystrom PV, Toledo-Pereyra LH. Molecular responses to ischemia and reperfusion in the liver. Arch Toxicol. 2015;89(5):651-657.
37. Girbl T, Lenn T, Perez L, et al. Distinct compartmentalization of the chemokines CXCL1 and CXCL2 and the atypical receptor ACKR1 determine discrete stages of neutrophil diapedesis. Immunity. 2018;49(6):1062-1076.e1066.
38. Lentsch AB, Yoshidome H, Cheadle WG, Miller FN, Edwards MJ. Chemokine involvement in hepatic ischemia/reperfusion injury in mice: roles for macrophage inflammatory protein-2 and Kupffer cells. Hepatology (Baltimore, MD). 1998;27(2):507-512.
39. Fan J, Malik AB. Toll-like receptor-4 (TLR4) signaling augments chemokine-induced neutrophil migration by modulating cell surface expression of chemokine receptors. Nat Med. 2003;9(3):315-321.
40. Uchida Y, Freitas MC, Zhao D, Busuttil RW, Kupiec-Weglinski JW. The protective function of neutrophil elastase inhibitor in liver ischemia/reperfusion injury. Transplantation. 2010;89(9):1050-1056.
41. Uchida Y, Ke B, Freitas MCS, et al. The emerging role of T cell immunoglobulin mucin-1 in the mechanism of liver ischemia and reperfusion injury in the mouse. Hepatology (Baltimore, MD). 2010;51(4):1363-1372.
42. Hirao H, Uchida Y, Kadono K, et al. The protective function of galectin-9 in liver ischemia and reperfusion injury in mice. Liver Transplant. 2015;21(7):969-981.
43. Uchida Y, Freitas MC, Zhao D, Busuttil RW, Kupiec-Weglinski JW. The inhibition of neutrophil elastase ameliorates mouse liver damage due to ischemia and reperfusion. Liver Transplant. 2009;15(8):939-947.
44. Uchida Y, Ke B, Freitas MCS, et al. T-cell immunoglobulin mucin-3 determines severity of liver ischemia/reperfusion injury in mice in a TLR4-dependent manner. Gastroenterology. 2010;139(6):2195-2206.
45. Ge M, Chen H, Zhu Q, et al. Propofol post-conditioning alleviates hepatic ischaemia reperfusion injury via BRG1-mediated Nrf2/ HO-1 transcriptional activation in human and mice. J Cell Mol Med. 2017;21(12):3693-3704.